Finally, it is crucially important to better understand reasons for the variable expression patterns of ERα in tumors, the nature of ER-negative cells in heterogeneous ER-positive tumors, the impact of hormonal therapies on these tumors and the mechanisms of the apparent conversion of some ER-positive to ER-negative tumors during cancer progression. Here, ERAL1 is linked to cancer.